(CBS) Warfarin may be the usual drug for preventing strokes in people with the heart rhythm problem known as atrial fibrillation, but a new study shows that an experimental blood thinner called apixaban works way better. In addition to being 21 percent less likely to have a stroke, people who took apixaban (Eliquis) were 31 […]
This report is part of a 12-month Clinical Context series. By Crystal Phend, Senior Staff Writer, MedPage Today Published: November 13, 2011 Reviewed by Michael Mullen, MD; Clinical Instructor of Vascular Neurology, University of Pennsylvania and Dorothy Caputo, MA, RN, BC-ADM, CDE, Nurse Planner ORLANDO — Atrial fibrillation that develops during severe sepsis predicts high […]
Francis Marion University hosted the 2011 American Heart Association’s Pee Dee Heart Walk on Oct. 29. Cold and rainy weather earlier in the morning tried to put a damper on the day, but participants and volunteers were still out in full force. Many people at the event were cold from the weather, so an instructor […]
New Results From the National Health and Wellness Survey Show Patients at High Risk for Stroke Have Lower Quality of Life, More Hospitalizations NEW YORK, NY, Nov 07, 2011 (MARKETWIRE via COMTEX) — Nearly 40% of diagnosed “high-risk” atrial fibrillation (AF) patients in the 5EU are not taking an anticoagulant to prevent stroke, according to […]
A study funded by the National Institutes of Health (NIH) has found that high blood pressure and other known risk factors for stroke also increase the risk of developing cognitive problems, even among people who have never had a stroke. The first author Frederick Unverzagt, PhD, and a professor of psychiatry at Indiana University School […]
On the eve of World Stroke Day, celebrated on 29 October 2011, the Public Health Agency (PHA) again gave a warning call against the deadly heart strokes. The PHA officials also accounted that if all the patients correctly notice the early dangerous stroke risks, then thousands of lives could be easily saved by effectively treating […]
